In light of the two studies mentioned that both outline MEG3 as a tumour suppressor molecule, more preclinical studies are required to solidify the use of MEG3 as a useful predictor of reduced metastasis in both lung cancer and NB. This evidence concerns the gene MEG3 and neoplasm.